OBJECTIVE: To describe the development of nevi from 3 to 8 years of age in a birth cohort of children in Colorado. DESIGN: Longitudinal observational study. SETTING: Large managed care organization and university and private primary care practices. PARTICIPANTS: Annual convenience samples of children born in 1998 (range, n = 137 to n = 870) (participation rates, 18.8%-76.0%). We recruited children through the managed care organization, private primary care practices, and community settings. MAIN OUTCOME MEASURES: Total whole body nevus counts, counts by nevus diameter (< 2, 2 to < 5, or > or = 5 mm), and counts for chronically and intermittently exposed body sites. RESULTS: Non-Hispanic white children had significantly more nevi than did other racial/ethnic groups and developed an average of 4 to 6 new nevi per year from 3 to 8 years of age. Non-Hispanic white boys had significantly more nevi than did girls beginning at 6 years of age (median, 21 [interquartile range, 28] vs 17 [17]; P = .002). This difference was due to nevi of less than 2 mm and nevi in chronically exposed body sites. Development of new nevi leveled off in chronically exposed body sites at 7 years of age and at a higher level for boys than girls. CONCLUSIONS: Children in Colorado developed more small nevi and fewer large nevi compared with children in other regions of the world, highlighting the importance of studying nevus development in various locations where sun exposure patterns and behavioral norms vary. The sex difference in nevus development could be owing to variation in sun exposure and/or a biological predisposition of boys to develop more nevi. Studies of nevus development can aid in the understanding of the complicated relationship between nevus development and malignant melanoma.
OBJECTIVE: To describe the development of nevi from 3 to 8 years of age in a birth cohort of children in Colorado. DESIGN: Longitudinal observational study. SETTING: Large managed care organization and university and private primary care practices. PARTICIPANTS: Annual convenience samples of children born in 1998 (range, n = 137 to n = 870) (participation rates, 18.8%-76.0%). We recruited children through the managed care organization, private primary care practices, and community settings. MAIN OUTCOME MEASURES: Total whole body nevus counts, counts by nevus diameter (< 2, 2 to < 5, or > or = 5 mm), and counts for chronically and intermittently exposed body sites. RESULTS: Non-Hispanic white children had significantly more nevi than did other racial/ethnic groups and developed an average of 4 to 6 new nevi per year from 3 to 8 years of age. Non-Hispanic white boys had significantly more nevi than did girls beginning at 6 years of age (median, 21 [interquartile range, 28] vs 17 [17]; P = .002). This difference was due to nevi of less than 2 mm and nevi in chronically exposed body sites. Development of new nevi leveled off in chronically exposed body sites at 7 years of age and at a higher level for boys than girls. CONCLUSIONS:Children in Colorado developed more small nevi and fewer large nevi compared with children in other regions of the world, highlighting the importance of studying nevus development in various locations where sun exposure patterns and behavioral norms vary. The sex difference in nevus development could be owing to variation in sun exposure and/or a biological predisposition of boys to develop more nevi. Studies of nevus development can aid in the understanding of the complicated relationship between nevus development and malignant melanoma.
Authors: E Azizi; J Iscovich; F Pavlotsky; R Shafir; I Luria; L Federenko; Z Fuchs; V Milman; E Gur; H Farbstein; O Tal Journal: Melanoma Res Date: 2000-10 Impact factor: 3.599
Authors: A Green; T Sorahan; D Pope; V Siskind; M Hansen; L Hanson; P Leech; P M Ball; R P Grimley Journal: Lancet Date: 1988 Dec 24-31 Impact factor: 79.321
Authors: Alan C Geller; Graham Colditz; Susan Oliveria; Karen Emmons; Cynthia Jorgensen; Gideon N Aweh; A Lindsay Frazier Journal: Pediatrics Date: 2002-06 Impact factor: 7.124
Authors: Elizabeth Milne; Robyn Johnston; Donna Cross; Billie Giles-Corti; Dallas R English Journal: Am J Epidemiol Date: 2002-04-15 Impact factor: 4.897
Authors: Ryan G Gamble; Nancy L Asdigian; Jenny Aalborg; Victoria Gonzalez; Neil F Box; Laura S Huff; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Lori A Crane; Robert P Dellavalle Journal: J Am Acad Dermatol Date: 2012-03-09 Impact factor: 11.527
Authors: J S Song; W B London; E B Hawryluk; D Guo; M Sridharan; D E Fisher; L E Lehmann; C N Duncan; J T Huang Journal: Bone Marrow Transplant Date: 2017-04-03 Impact factor: 5.483
Authors: Haoming Xu; Michael A Marchetti; Stephen W Dusza; Esther Chung; Maira Fonseca; Alon Scope; Alan C Geller; Marilyn Bishop; Ashfaq A Marghoob; Allan C Halpern Journal: JAMA Dermatol Date: 2017-10-01 Impact factor: 10.282
Authors: Jenny Aalborg; Joseph G Morelli; Tim E Byers; Stefan T Mokrohisky; Lori A Crane Journal: J Am Acad Dermatol Date: 2010-06-26 Impact factor: 11.527
Authors: Lori A Crane; Nancy L Asdigian; Anna E Barón; Jenny Aalborg; Alfred C Marcus; Stefan T Mokrohisky; Tim E Byers; Robert P Dellavalle; Joseph G Morelli Journal: Am J Prev Med Date: 2012-10 Impact factor: 5.043
Authors: Anna E Barón; Nancy L Asdigian; Victoria Gonzalez; Jenny Aalborg; Tamara Terzian; Regan A Stiegmann; Enrique C Torchia; Marianne Berwick; Robert P Dellavalle; Joseph G Morelli; Stefan T Mokrohisky; Lori A Crane; Neil F Box Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-12 Impact factor: 4.254
Authors: Nancy L Asdigian; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Jenny Aalborg; Robert P Dellavalle; Matthew F Daley; Marianne Berwick; Keith E Muller; Neil F Box; Lori A Crane Journal: JAMA Dermatol Date: 2018-11-01 Impact factor: 10.282
Authors: Kelly J Pettijohn; Nancy L Asdigian; Jenny Aalborg; Joseph G Morelli; Stefan T Mokrohisky; Robert P Dellavalle; Lori A Crane Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-02-03 Impact factor: 4.254